Effective drug development and clinical pharmacology programs

Design

Design of clinical pharmacology studies and program characterizing the pharmacokinetics and time course of effect

 

 

Analysis

Exposure response anaylsis to estimate the optimal dose based on the population and individual characteristics

 

 

Interpretation

Interpret PK, effect data, drug interactions, food effect, renal and hepatic impairment, age, race and patient characteristics    

 

We offer clinical pharmacology consulting that you can depend on, based on 25+ years of experience and close customer relationships.

 

Milad Pharmaceutical offers pharmacokinetic and pharmacodynamic analysis, clinical pharmacology expertise, and drug development strategy.

 

Development programs are streamlined by improving the efficiency of the Pre-IND phase to Phase II by applying pharmacokinetic, exposure response analysis, model informed drug development analysis and interpretation.

 

 

At Milad Pharmaceutical Consulting, the long-standing and trustful relationships we have with our clients, both large and small pharmaceutical companies, are based on good communication, timely analysis, and clear interpretation of results.

 

Continuous reciprocal communication and leveraged experience between Milad Pharma and clients forms the basis of the success.

Optimal design of drug development programs and pharmaceutical studies ensures the availability of essential data needed to drive timely decision making and regulatory preparedness.

 

 

Dose selection, program efficiency, and regulatory goals
united using model-informed drug development

Print Print | Sitemap
Copyright © 2018. Milad Pharmaceutical Consulting. All Rights Reserved.